(Q54314497)
Statements
Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis. (English)
1 reference
Ekbom K
1 reference
Lundberg PO
1 reference
1 April 1972
1 reference
1 reference
12
1 reference
15-17
1 reference
1
1 reference
Identifiers
1 reference